Press Releases
New Analyses on Mortality from the 18,924-Patient ODYSSEY OUTCOMES Trial
Regeneron Pharmaceuticals, Inc. and Sanofi announced that new analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association...
Clinical Trials
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV
AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial. ...
Research Insight
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment...
Press Releases
Quanticate Sponsors Research into Response Adaptive Trial Design
Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. ...
Press Releases
Zenith Technologies Launches Virtual Manufacturing System Training Service
Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, has launched a new virtual customised training service...
News
Lonza’s Global Subject Matter Expert for Endotoxin Detection Appointed Chair of ASMFC Horseshoe Crab Advisory Panel
Lonza announced the appointment of Allen Burgenson, Global Subject Matter Expert for Endotoxin Detection at Lonza, as Chair of the Horseshoe Crab Advisory Panel...
News
LANXESS to strengthen its Indian production sites
Specialty chemicals company LANXESS is strengthening its asset base in India. The company plans to invest up to INR 1250 crores...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read